Home
About
Overview
Sharing Data
ORCID
Help
History (6)
Integrative cross-omics and cross-context analysis elucidates molecular links underlying genetic effects on complex traits.
International neural monitoring study group guideline 2018 part I: Staging bilateral thyroid surgery with monitoring loss of signal.
TCR sequencing analysis of cancer tissues and tumor draining lymph nodes in colorectal cancer patients.
Telephone based cognitive behavioral therapy targeting major depression among urban dwelling, low income people living with HIV/AIDS: results of a randomized controlled trial.
Enzalutamide for the Treatment of Androgen Receptor-Expressing Triple-Negative Breast Cancer.
See All 6 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Enzalutamide for the Treatment of Androgen Receptor-Expressing Triple-Negative Breast Cancer.
Enzalutamide for the Treatment of Androgen Receptor-Expressing Triple-Negative Breast Cancer. J Clin Oncol. 2018 03 20; 36(9):884-890.
View in:
PubMed
subject areas
Adult
Aged
Aged, 80 and over
Antineoplastic Agents
Benzamides
Female
Humans
Immunohistochemistry
Kaplan-Meier Estimate
Middle Aged
Neoplasm Metastasis
Nitriles
Phenylthiohydantoin
Receptors, Androgen
Triple Negative Breast Neoplasms
authors with profiles
Rita Nanda